Regarding verapamil, which one of the following statements is false?

Questions 52

ATI RN

ATI RN Test Bank

Chapter 11 Cardiovascular Drugs Test Questions Quizlet Questions

Question 1 of 5

Regarding verapamil, which one of the following statements is false?

Correct Answer: B

Rationale: Verapamil is a calcium channel blocker commonly used to treat various cardiovascular conditions. In this question, the false statement is option B - "Contraindicated in the asthmatic patient." Verapamil is not contraindicated in asthmatic patients; however, caution is advised in patients with significant left ventricular dysfunction or heart failure. Option A is correct because angina pectoris is indeed an important indication for using verapamil. Verapamil helps dilate coronary arteries, improving blood flow to the heart muscle and reducing the workload on the heart. Option C is correct as verapamil relaxes vascular smooth muscle, leading to vasodilation. This property helps lower blood pressure and improve blood flow throughout the body. Option D is correct as verapamil slows the depolarization phase of the action potential in AV nodal cells. This effect is why it is commonly used to treat certain arrhythmias by slowing down the electrical conduction in the heart. In an educational context, understanding the pharmacological actions of verapamil is crucial for healthcare providers managing patients with cardiovascular conditions. Knowing the indications, contraindications, and effects of verapamil helps ensure safe and effective medication administration. It also highlights the importance of careful consideration based on individual patient characteristics when prescribing cardiovascular drugs.

Question 2 of 5

For a longer duration of action nitroglycerine can be administered by which of the following routes

Correct Answer: D

Rationale: In the context of cardiovascular drugs and specifically nitroglycerine, administering it via cutaneous application (Option D) allows for a longer duration of action. This is because when nitroglycerine is applied cutaneously, it is absorbed more slowly through the skin, leading to a sustained release of the medication into the bloodstream. Sublingual administration (Option A) of nitroglycerine is known for its rapid onset of action but does not provide the same extended duration as cutaneous application. Inhalation (Option B) and intravenous administration (Option C) also offer rapid effects, but again, they do not offer the prolonged duration of action that cutaneous application provides. Educationally, understanding the various routes of drug administration is crucial for healthcare professionals, especially those dealing with cardiovascular medications. Knowing the specific characteristics of each route helps in selecting the most appropriate method based on the desired onset and duration of action for optimal patient care and outcomes. In the case of nitroglycerine, choosing cutaneous application for a longer-lasting effect can be beneficial in certain clinical scenarios, which underscores the importance of this knowledge in clinical practice.

Question 3 of 5

The client is taking Flecainide for arrhythmias. What type of anti-arrhythmic medication is this:

Correct Answer: D

Rationale: In this question, the correct answer is D) Class IC. Flecainide belongs to the Class IC anti-arrhythmic drugs. These drugs work by blocking sodium channels in the heart, leading to a decrease in the rate of depolarization and conduction velocity. This helps to stabilize the heart's rhythm in conditions like arrhythmias. Option A) Class IB drugs work by blocking sodium channels but with different kinetics compared to Class IC drugs. Option B) Class II drugs are beta-blockers that act on beta-adrenergic receptors to reduce sympathetic stimulation of the heart. Option C) is a duplication of Option A. In an educational context, understanding the classification of anti-arrhythmic drugs is crucial for healthcare professionals, especially those working in cardiology or critical care settings. Knowing the mechanisms of action and classifications helps in selecting the most appropriate medication for a specific arrhythmia and understanding how each drug will impact the heart's electrical activity. This knowledge is essential for safe and effective patient care.

Question 4 of 5

The client has hypertension. Which drug the client is taking has an effect on blood pressure?

Correct Answer: A

Rationale: In this scenario, the correct answer is A) Dyazide. Dyazide is a combination medication containing hydrochlorothiazide and triamterene, which are diuretics that help lower blood pressure by reducing fluid volume in the body. This effect on fluid balance helps to decrease the workload on the heart, thus lowering blood pressure in hypertensive patients. Option B) Metformin is actually an antidiabetic medication used to treat type 2 diabetes by improving insulin sensitivity and reducing glucose production in the liver. It does not have a direct effect on blood pressure. Option C) Digoxin is a medication used to treat heart failure and certain heart rhythm disorders by increasing the strength of the heart muscle contractions. While it can help with heart function, it does not directly lower blood pressure. Option D) Warfarin is an anticoagulant medication used to prevent blood clots. While it can indirectly impact blood pressure if high blood pressure leads to clot formation, its primary mechanism of action is not related to lowering blood pressure. In an educational context, understanding the mechanisms of action of different cardiovascular drugs is crucial for healthcare professionals to make informed decisions when managing patients with hypertension. By knowing how each drug works, practitioners can tailor treatment plans to effectively control blood pressure and improve patient outcomes.

Question 5 of 5

A 62-year-old man has developed worsening hypertension despite therapy. His physician wants to prescribe an additional medication that will dilate his blood vessels to help lower his blood pressure. Which of the following is a calcium channel blocker that works primarily on vascular smooth muscle?

Correct Answer: A

Rationale: The correct answer is A) Amlodipine. Amlodipine is a calcium channel blocker that primarily works on vascular smooth muscle to dilate blood vessels, leading to a reduction in blood pressure. This medication inhibits the influx of calcium ions into vascular smooth muscle cells, resulting in relaxation and vasodilation. Option B) Diltiazem is also a calcium channel blocker, but it mainly acts on the heart and is used to treat conditions like angina and certain heart rhythm disorders, rather than primarily targeting vascular smooth muscle for blood pressure reduction. Option C) Losartan is an angiotensin II receptor blocker (ARB) that works by blocking the effects of angiotensin II on blood vessels, leading to vasodilation and decreased blood pressure. However, it does not directly target calcium channels in vascular smooth muscle like amlodipine. Option D) Nitroprusside is a potent vasodilator that acts by releasing nitric oxide to relax vascular smooth muscle. While it can rapidly lower blood pressure in emergency situations, it does not primarily act as a calcium channel blocker like amlodipine does. Understanding the mechanisms of action of different cardiovascular drugs is crucial for healthcare professionals to make informed decisions when prescribing medications for patients with hypertension. Knowing the specific actions of medications like calcium channel blockers helps tailor treatment regimens to individual patient needs, optimizing therapeutic outcomes and minimizing adverse effects.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions